Track ContextVision AB (publ) — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

ContextVision AB (publ) CONTX.OL Open ContextVision AB (publ) in new tab

3.60 NOK
P/E
368.00
EPS
0.01
P/B
3.09
ROE
5.17
Beta
0.23
Loading chart...
Key Metrics
Earnings dateAug. 27, 2026
P/E368.00
EPS0.01
Book Value1.19
Price to Book3.09
Debt/Equity12.87
% Insiders64.320%
Growth
Revenue Growth0.09%
Earnings Growth-0.43%
Estimates
Forward P/E19.37
Forward EPS0.19

DCF Valuation

Tweak assumptions to recompute fair value for ContextVision AB (publ) (CONTX.OL)
Currency: NOK
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

ContextVision AB (publ) Logo ContextVision AB (publ) Analysis (CONTX.OL)

Sweden Health Care Official Website Stock

Is ContextVision AB (publ) a good investment? ContextVision AB (publ) (CONTX.OL) is currently trading at 3.60 NOK.

In terms of valuation, the stock trades at a P/E ratio of 368.00. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: ContextVision AB (publ) is expected to release its next earnings report on Aug. 27, 2026. The market consensus estimate for Forward EPS is 0.19.

Investor FAQ

Does ContextVision AB (publ) pay a dividend?

No, it does not currently pay a dividend.

What asset class is ContextVision AB (publ)?

ContextVision AB (publ) is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 27, 2026. The company currently has a trailing EPS of 0.01.

Company Profile

ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardiology, women's health, veterinary medicine, and point of-care applications. It also provides Altumira platform, which features scatter correction and improves radiography by enabling radiation dose reduction while enhancing image quality, such as Altumira for static applications; and Altumira Plus for dynamic applications. In addition, the company offers image quality solutions for MRI including GOPView MRI2Plus for the requirements of each application, sequence type, and protocol; and implementation projects, software updates, and upgrades and product support services. It has a strategic clinical development partnership with the University of Washington to identify a multiparametric biomarker for the screening and staging of the liver disease MASLD; and research partnership with AMRA Medical. ContextVision AB (publ) was incorporated in 1989 and is headquartered in Stockholm, Sweden.

Exchange Ticker
OSL (Norway) CONTX.OL
Historical Dividends
Year Total Dividends
2023 0.30 NOK
2008 1.28 NOK

Yearly aggregated dividends

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
Aug. 19, 2020 10.000000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion